Lung cancer UK price tag eclipses the cost of any other cancer, study finds

November 7, 2012, Cancer Research UK
Lung cancer uk price tag eclipses the cost of any other cancer

The cost of lung cancer to the UK economy is £2.4 billion each year, far higher than the cost of any other cancer. This highlights the urgent need to continue to reduce the number of young people who become addicted to tobacco – as smoking causes more than eight in 10 lung cancers in the UK. The research is presented at the NCRI Cancer Conference in Liverpool today (Wednesday).

The same Oxford University study found that the total annual cost of all cancers to the is £15.8bn. Half (£7.6bn) of the total economic cost of cancer to the UK is due to premature deaths and time off work, followed by healthcare costs (35 per cent, £5.6bn) and unpaid care to cancer patients by friends and family (16 per cent, £2.6bn). represents a cost of £90 per person in the UK population.

Each lung cancer patient costs the UK healthcare system £9,071 annually. This compares with £2,756 for , £1,584 for prostate cancer and £1,076 for . The average healthcare spend on each cancer patient in the UK is £2,776.

Research author, Dr Jose Leal, at the Health Economics Research Centre, University of Oxford, said: "Lung cancer costs more than any other cancer – mainly because of potential wage losses due to premature deaths from people in employment - about 60 per cent of the total economic costs – and high . The death rate from the disease remains high at 56 deaths per 100,000 people in the UK population annually, and almost a quarter of these occur before retirement.

"Our research shows that cancers impact the economy as a whole - and not just the health service. , time off work and unpaid care by friends and family account for 64 per cent of all cancer costs (£10.2bn) in the UK in 2009. These wider costs should be taken into account when deciding research priorities. Cancers with the highest economic cost could offer the highest expected returns from investment in research."

Each year in the UK in the UK 41,500 people are diagnosed with lung cancer and almost 35,000 people die from the disease. Around 157,000 children aged 11-15 start smoking in the UK each year, enough to fill over 5,000 classrooms.

Dr Jane Cope, director of the NCRI, said: "These figures remind us that cancer has a cost, not just in professional healthcare but also in loss of earnings for patients, and for loved ones who give up work to look after them. Since 86 per cent of lung cancer deaths are linked to smoking, we can reduce these financial and societal costs by helping people to stop smoking."

Explore further: People fear cancer more than other serious illness

More information: "The economic burden of lung cancer across the European Union," Dr Jose Leal, University of Oxford. www.ncri.org.uk/ncriconference … rallel_Jose_Leal.asp

Related Stories

People fear cancer more than other serious illness

August 16, 2011
More than a third of people in the UK fear cancer more than other life-threatening conditions – such as Alzheimer’s, stroke and heart disease according to a Cancer Research UK survey.

Cancer is the biggest premature killer

November 3, 2011
Cancer is responsible for killing 40 per cent of all the men and women who die prematurely between the ages of 25 and 74 in the UK – according to a new analysis of the figures released today by Cancer Research UK.

Bowel screening reduces cancer deaths by more than 25 per cent

November 9, 2011
(Medical Xpress) -- Bowel screening reduces the number of deaths from bowel cancer in Scotland by more than 25 per cent, according to research* presented at the National Cancer Research Institute (NCRI) Cancer Conference ...

Cancer death rates set to drop 17 per cent by 2030

September 25, 2012
(Medical Xpress)—The rates of people dying from cancer are predicted to fall by 17 per cent (16.8) in the UK by 2030 according to new statistics released today by Cancer Research UK.

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.